• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 APHERESIS PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 APHERESIS PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number A710962
Medical Device Problem Codes Fracture (1260); Suction Problem (2170)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/30/2025
Type of Reportable Event Malfunction
Event or Problem Description
On (b)(6) 2022, a patient underwent a port placement procedure using the apheresis port.On (b)(6) 2025, the device could not be aspirated.It was further reported that upon checking it was noted that the catheter allegedly fractured at the internal jugular vein.Reportedly, the port was removed.There was no reported patient injury.
 
Additional Manufacturer Narrative
H11: as the lot number for the device was not provided, a review of the device history records could not be performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
On (b)(6) 2022, a patient underwent a port placement procedure using the apheresis port.On (b)(6) 2025, the device could not be aspirated.Upon checking it was noted that the catheter allegedly fractured at the internal jugular vein.Port was removed.There was no reported patient injury.
 
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed, and this lot met all release criteria.Investigation summary: one powerflow apheresis implantable port with an attached catheter was returned for evaluation.Visual, microscopic, tactile and functional evaluations were performed.A longitudinal split was noted approximately 2.6cm from the distal end of the cath-lock.The distal catheter segment was not returned.The edges of the longitudinal split on the attached catheter were noted to be uneven.The surface could not be determined as additional damage would be caused in area.Aspiration was attempted and was unsuccessful only air returned to the in-house syringe attached.Therefore, the investigation is confirmed for the reported fracture and suction issues.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.D4 (unique identifier (udi) #), g2, g3, h6 (method, result, conclusion) section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APHERESIS PORT
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key22313362
Report Number3006260740-2025-04202
Device Sequence Number8948405
Product Code PTD
UDI-Device Identifier00801741129438
UDI-Public(01)00801741129438(11)220517(17)230630(10)REGN2267
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K163001
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2025
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/25/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/30/2023
Device Catalogue NumberA710962
Device Lot NumberREGN2267
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/09/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/30/2025
Supplement Date Received by Manufacturer08/25/2025
Initial Report FDA Received Date06/24/2025
Supplement Report FDA Received Date09/03/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/17/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-